{
  "abstract": "Cancer clinical trials in the UK are at a critical juncture. They face significant systemic pressures within the NHS and regulatory pathways that threaten efficiency and timeliness. Both commercial and non-commercial trials are vital for advancing cancer treatment and improving patient outcomes. However, non-commercial trials, which are key to tackling rare and hard-to-treat cancers and treatments with limited commercial interest (eg, radiotherapy and surgery), must not be left behind.",
  "authors": [
    {
      "affiliations": [
        "Cancer Research UK"
      ],
      "name": "Ellie Jones"
    },
    {
      "affiliations": [
        "Cancer Research UK"
      ],
      "name": "Catherine Elliott"
    },
    {
      "affiliations": [
        "Cancer Research UK"
      ],
      "name": "Charles Swanton"
    }
  ],
  "title": "No time to waste—we need to start cancer clinical trials faster",
  "uid": "d98a8cf3-ee6b-5d9b-a03d-8a79ee8eec05"
}